FDC Ltd, a Rs 600 crore plus Mumbai based pharma major, has achieved satisfactory performance during the year ended March 2009. Its net profit increased by 36.5 per cent to Rs 86.21 crore as against Rs 63.17 crore and its net sales moved up by 19 per cent to Rs 589.13 crore from Rs 495.12 crore. The earning per share touched to Rs 4.52 as compared to Rs 3.30 in the last year.

The board of directors has recommended a dividend of Rs 1.25 per share (125 per cent) for the financial year 2008-09.

FDC has bought back, through open market, 32,91,869 equity share of Rs 1 each during 2008-09. Due to this, its equity capital reduced to Rs 18.82 crore from Rs 19.14 crore in the last year. Its reserves and surplus increased by 13.8 per cent to Rs 402.98 crore from Rs 354 crore in the previous year.